FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015744471> ?p ?o ?g. }

• W2015744471 endingPage "501" @default.
• W2015744471 startingPage "493" @default.
• W2015744471 abstract "The three mini‐reviews this month cover several areas of interest, including premature ejaculation, urological malignancies after renal transplantation and the much‐vexed issue of the relevance of prostate size to prostate disease. Each of these should help to keep the readers up‐to‐date with each of these important topics. We examine the progress that has been made towards the development of topical treatments for premature ejaculation (PE). Although generally regarded as one of the most common male sexual problems, the lack of approved pharmacological agents for PE means that treatment options are limited to behavioural therapy, where available, and the use of drugs ‘off‐label’. There are various theories on the aetiology of PE, but it seems likely that both biological and psychological factors are important. One theory, that men with PE might have a heightened sensory response to penile stimulation, provides the rationale for using topical therapy; reducing the sensitivity of the glans penis with topical desensitizing agents (e.g. local anaesthetics) might improve ejaculatory latency without adversely affecting the sensation of ejaculation. Off‐label topical treatments are now relatively widely used, despite limited supportive efficacy data. There are also new topical treatments in various stages of development, designed specifically for use in PE. Treatments reviewed include TEMPE spray, containing a eutectic mixture of the topical anaesthetics lidocaine and prilocaine, and several creams, including one containing natural products (SS‐cream), and preliminary results from another containing the local anaesthetic dylonine, with alprostadil (prostaglandin E1). Despite wide variations in the methods of clinical trials, it is possible to conclude that all placebo‐controlled studies of topical treatments have reported a significant increase in intravaginal ejaculatory latency time compared to baseline and placebo. Topical treatments for PE are appealing in that they can be applied as needed and only minimal systemic effects are likely. However, without well‐controlled drug delivery there is the theoretical possibility of penile hypoaesthesia and/or transvaginal contamination. Unlike the cream formulations, the TEMPE spray has a well‐controlled delivery system, making it easy to administer locally, and it appears to be well tolerated in early clinical trials. It appears that topical treatments might be able to satisfy many of the requirements of an ideal treatment for PE, and certainly have the potential for use as a first‐line treatment." @default.
• W2015744471 created "2016-06-24" @default.
• W2015744471 creator A5025873791 @default.
• W2015744471 creator A5053548238 @default.
• W2015744471 creator A5069396064 @default.
• W2015744471 date "2007-07-31" @default.
• W2015744471 modified "2023-10-18" @default.
• W2015744471 title "A review of the current status of topical treatments for premature ejaculation" @default.
• W2015744471 cites W1676574427 @default.
• W2015744471 cites W1771433814 @default.
• W2015744471 cites W1979651639 @default.
• W2015744471 cites W1986965347 @default.
• W2015744471 cites W1995556355 @default.
• W2015744471 cites W2007853080 @default.
• W2015744471 cites W2011572925 @default.
• W2015744471 cites W2014375009 @default.
• W2015744471 cites W2019776595 @default.
• W2015744471 cites W2025181822 @default.
• W2015744471 cites W2027757465 @default.
• W2015744471 cites W2029805821 @default.
• W2015744471 cites W2041134193 @default.
• W2015744471 cites W2041600461 @default.
• W2015744471 cites W2042070221 @default.
• W2015744471 cites W2044619239 @default.
• W2015744471 cites W2044821452 @default.
• W2015744471 cites W2058690971 @default.
• W2015744471 cites W2061997603 @default.
• W2015744471 cites W2069253409 @default.
• W2015744471 cites W2071981939 @default.
• W2015744471 cites W2074693545 @default.
• W2015744471 cites W2075063659 @default.
• W2015744471 cites W2080104166 @default.
• W2015744471 cites W2085303538 @default.
• W2015744471 cites W2086193216 @default.
• W2015744471 cites W2088639391 @default.
• W2015744471 cites W2093780154 @default.
• W2015744471 cites W2133586909 @default.
• W2015744471 cites W2134401797 @default.
• W2015744471 cites W2142312342 @default.
• W2015744471 cites W2142521961 @default.
• W2015744471 cites W2143484005 @default.
• W2015744471 cites W2157949209 @default.
• W2015744471 cites W2312536652 @default.
• W2015744471 cites W2734682486 @default.
• W2015744471 cites W2791609429 @default.
• W2015744471 cites W4255396331 @default.
• W2015744471 doi "https://doi.org/10.1111/j.1464-410x.2007.07051.x" @default.
• W2015744471 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17608824" @default.
• W2015744471 hasPublicationYear "2007" @default.
• W2015744471 type Work @default.
• W2015744471 sameAs 2015744471 @default.
• W2015744471 citedByCount "68" @default.
• W2015744471 countsByYear W20157444712012 @default.
• W2015744471 countsByYear W20157444712013 @default.
• W2015744471 countsByYear W20157444712014 @default.
• W2015744471 countsByYear W20157444712015 @default.
• W2015744471 countsByYear W20157444712016 @default.
• W2015744471 countsByYear W20157444712017 @default.
• W2015744471 countsByYear W20157444712019 @default.
• W2015744471 countsByYear W20157444712020 @default.
• W2015744471 countsByYear W20157444712021 @default.
• W2015744471 countsByYear W20157444712022 @default.
• W2015744471 countsByYear W20157444712023 @default.
• W2015744471 crossrefType "journal-article" @default.
• W2015744471 hasAuthorship W2015744471A5025873791 @default.
• W2015744471 hasAuthorship W2015744471A5053548238 @default.
• W2015744471 hasAuthorship W2015744471A5069396064 @default.
• W2015744471 hasBestOaLocation W20157444711 @default.
• W2015744471 hasConcept C11171543 @default.
• W2015744471 hasConcept C141071460 @default.
• W2015744471 hasConcept C15744967 @default.
• W2015744471 hasConcept C177713679 @default.
• W2015744471 hasConcept C2777786686 @default.
• W2015744471 hasConcept C2778598218 @default.
• W2015744471 hasConcept C2779892816 @default.
• W2015744471 hasConcept C2780149897 @default.
• W2015744471 hasConcept C2780560023 @default.
• W2015744471 hasConcept C71924100 @default.
• W2015744471 hasConceptScore W2015744471C11171543 @default.
• W2015744471 hasConceptScore W2015744471C141071460 @default.
• W2015744471 hasConceptScore W2015744471C15744967 @default.
• W2015744471 hasConceptScore W2015744471C177713679 @default.
• W2015744471 hasConceptScore W2015744471C2777786686 @default.
• W2015744471 hasConceptScore W2015744471C2778598218 @default.
• W2015744471 hasConceptScore W2015744471C2779892816 @default.
• W2015744471 hasConceptScore W2015744471C2780149897 @default.
• W2015744471 hasConceptScore W2015744471C2780560023 @default.
• W2015744471 hasConceptScore W2015744471C71924100 @default.
• W2015744471 hasIssue "3" @default.
• W2015744471 hasLocation W20157444711 @default.
• W2015744471 hasLocation W20157444712 @default.
• W2015744471 hasOpenAccess W2015744471 @default.
• W2015744471 hasPrimaryLocation W20157444711 @default.
• W2015744471 hasRelatedWork W139861034 @default.
• W2015744471 hasRelatedWork W159258829 @default.
• W2015744471 hasRelatedWork W1999451271 @default.
• W2015744471 hasRelatedWork W2043094772 @default.
• W2015744471 hasRelatedWork W2094172135 @default.

• next